TNF-α and its receptors modulate complex behaviours and neurotrophins in transgenic mice

Psychoneuroendocrinology

Volumn 38, Issue 12, 2013, Pages 3102-3114

  Camara, Marie Lou ^a,b   Corrigan, Frances ^a   Jaehne, Emily J ^a   Jawahar, M Catharine ^a   Anscomb, Helen ^b   Koerner, Heinrich ^c   Baune, Bernhard T ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b JAMES COOK UNIVERSITY   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Anxiety; Cognition; Depression; Neurogenesis; Neurotrophins; Sociability; TNF ; TNF R1; TNF R2

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR; CELL PROLIFERATION; COGNITION; CONTROLLED STUDY; DENTATE GYRUS; DEPRESSION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPLORATORY BEHAVIOR; FEMALE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LEARNING; LEARNING DISORDER; LOCOMOTION; MALE; MEMORY DISORDER; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEUROMODULATION; NONHUMAN; PHENOTYPE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SOCIAL INTERACTION; SPATIAL MEMORY;

ANXIETY; COGNITION; DEPRESSION; NEUROGENESIS; NEUROTROPHINS; SOCIABILITY; TNF-R1; TNF-R2; TNF-Α;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; DEPRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXPLORATORY BEHAVIOR; FEMALE; IMMUNOHISTOCHEMISTRY; INTERPERSONAL RELATIONS; LEARNING; MALE; MAZE LEARNING; MEMORY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MOTOR ACTIVITY; NERVE GROWTH FACTORS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RECOGNITION (PSYCHOLOGY); SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84888286148     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2013.09.010     Document Type: Article

References (58)

1. Barker V., Middleton G., Davey F., Davies A.M. TNFalpha contributes to the death of NGF-dependent neurons during development. Nat. Neurosci. 2001, 4:1194-1198.
2. Baune B.T., Camara M.-L., Eyre H., Jawahar C., Anscomb H., Koerner H. Tumour necrosis factor alpha mediated mechanisms of cognitive dysfunction. Trends Neurosci. 2012, 3:263-277.
3. Baune B.T., Wiede F., Braun A., Golledge J., Arolt V., Koerner H. Cognitive dysfunction in mice deficient for TNF- and its receptors. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2008, 147B:1056-1064.
4. Beattie E.C., Stellwagen D., Morishita W., Bresnahan J.C., Ha B.K., Von Zastrow M., Beattie M.S., Malenka R.C. Control of synaptic strength by glial TNFalpha. Science 2002, 295:2282-2285.
5. Bernardini R., Kamilaris T.C., Calogero A.E., Johnson E.O., Gomez M.T., Gold P.W., Chrousos G.P. Interactions between tumor necrosis factor-alpha, hypothalamic corticotropin-releasing hormone, and adrenocorticotropin secretion in the rat. Endocrinology 1990, 126:2876-2881.
6. Bette M., Kaut O., Schafer M.K., Weihe E. Constitutive expression of p55TNFR mRNA and mitogen-specific up-regulation of TNF alpha and p75TNFR mRNA in mouse brain. J. Comp. Neurol. 2003, 465:417-430.
7. Biebl M., Cooper C.M., Winkler J., Kuhn H.G. Analysis of neurogenesis and programmed cell death reveals a self-renewing capacity in the adult rat brain. Neurosci. Lett. 2000, 291:17-20.
8. Bruce A.J., Boling W., Kindy M.S., Peschon J., Kraemer P.J., Carpenter M.K., Holtsberg F.W., Mattson M.P. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat. Med. 1996, 2:788-794.
9. Castren E., Voikar V., Rantamaki T. Role of neurotrophic factors in depression. Curr. Opin. Pharmacol. 2007, 7:18-21.
10. Cheng B., Christakos S., Mattson M.P. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 1994, 12:139-153.
11. Choy K.H., de Visser Y., Nichols N.R., van den Buuse M. Combined neonatal stress and young-adult glucocorticoid stimulation in rats reduce BDNF expression in hippocampus: effects on learning and memory. Hippocampus 2008, 18:655-667.
12. Clark I.A., Alleva L.M., Vissel B. The roles of TNF in brain dysfunction and disease. Pharmacol. Ther. 2010, 128:519-548.
13. Cryns K., Shamir A., Shapiro J., Daneels G., Goris I., Van Craenendonck H., Straetemans R., Belmaker R.H., Agam G., Moechars D., Steckler T. Lack of lithium-like behavioral and molecular effects in IMPA2 knockout mice. Neuropsychopharmacology 2007, 32:881-891.
14. Davidson R.J. Anxiety and affective style: role of prefrontal cortex and amygdala. Biol. Psychiatry 2002, 51:68-80.
15. Dean B., Tawadros N., Scarr E., Gibbons A.S. Regionally-specific changes in levels of tumour necrosis factor in the dorsolateral prefrontal cortex obtained postmortem from subjects with major depressive disorder. J. Affect. Disord. 2010, 120:245-248.
16. Dopp J.M., Mackenzie-Graham A., Otero G.C., Merrill J.E. Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia. J. Neuroimmunol. 1997, 75:104-112.
17. Dulawa S.C., Grandy D.K., Low M.J., Paulus M.P., Geyer M.A. Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. J. Neurosci. 1999, 19:9550-9556.
18. Eisener-Dorman A.F., Lawrence D.A., Bolivar V.J. Cautionary insights on knockout mouse studies: the gene or not the gene?. Brain Behav. Immun. 2009, 23:318-324.
19. Erickson S.L., de Sauvage F.J., Kikly K., Carver-Moore K., Pitts-Meek S., Gillett N., Sheehan K.C., Schreiber R.D., Goeddel D.V., Moore M.W. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 1994, 372:560-563.
20. Fontaine V., Mohand-Said S., Hanoteau N., Fuchs C., Pfizenmaier K., Eisel U. Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J. Neurosci. 2002, 22:RC216.
21. Furukawa K., Mattson M.P. The transcription factor NF-kappaB mediates increases in calcium currents and decreases in NMDA- and AMPA/kainate-induced currents induced by tumor necrosis factor-alpha in hippocampal neurons. J. Neurochem. 1998, 70:1876-1886.
22. Gary D.S., Bruce-Keller A.J., Kindy M.S., Mattson M.P. Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J. Cereb. Blood Flow Metab. 1998, 18:1283-1287.
23. Gilmore J.H., Jarskog L.F., Vadlamudi S. Maternal infection regulates BDNF and NGF expression in fetal and neonatal brain and maternal-fetal unit of the rat. J. Neuroimmunol. 2003, 138:49-55.
24. Golan H., Levav T., Mendelsohn A., Huleihel M. Involvement of tumor necrosis factor alpha in hippocampal development and function. Cereb. Cortex 2004, 14:97-105.
25. Hart P.C., Bergner C.L., Smolinsky A.N., Dufour B.D., Egan R.J., Laporte J.L., Kalueff A.V. Experimental models of anxiety for drug discovery and brain research. Methods Mol. Biol. 2010, 602:299-321.
26. Horiuchi T., Mitoma H., Harashima S., Tsukamoto H., Shimoda T. Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents. Rheumatology (Oxford) 2010, 49:1215-1228.
27. Iosif R.E., Ekdahl C.T., Ahlenius H., Pronk C.J., Bonde S., Kokaia Z., Jacobsen S.E., Lindvall O. Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis. J. Neurosci. 2006, 26:9703-9712.
28. Kassiotis G., Kollias G. Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination. J. Exp. Med. 2001, 193:427-434.
29. Kaster M.P., Gadotti V.M., Calixto J.B., Santos A.R.S., Rodrigues A.L.S. Depressive-like behavior induced by tumor necrosis factor-α in mice. Neuropharmacology 2012, 62:419-426.
30. Kopp C. Locomotor activity rhythm in inbred strains of mice: implications for behavioural studies. Behav. Brain Res. 2001, 125:93-96.
31. Korner H., Cook M., Riminton D.S., Lemckert F.A., Hoek R.M., Ledermann B., Kontgen F., Fazekas de St Groth B., Sedgwick J.D. Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur. J. Immunol. 1997, 27:2600-2609.
32. Lad H.V., Liu L., Paya-Cano J.L., Parsons M.J., Kember R., Fernandes C., Schalkwyk L.C. Behavioural battery testing: evaluation and behavioural outcomes in 8 inbred mouse strains. Physiol. Behav. 2010, 99:301-316.
33. Li J., Ramenaden E.R., Peng J., Koito H., Volpe J.J., Rosenberg P.A. Tumor necrosis factor alpha mediates lipopolysaccharide-induced microglial toxicity to developing oligodendrocytes when astrocytes are present. J. Neurosci. 2008, 28:5321-5330.
34. McAfoose J., Baune B.T. Evidence for a cytokine model of cognitive function. Neurosci. Biobehav. Rev. 2009, 33:355-366.
35. McAfoose J., Koerner H., Baune B.T. The effects of TNF deficiency on age-related cognitive performance. Psychoneuroendocrinology 2009, 34:615-619.
36. McCoy M.K., Tansey M.G. TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J. Neuroinflammation 2008, 5:45.
37. Miller E.K., Cohen J.D. An integrative theory of prefrontal cortex function. Annu. Rev. Neurosci. 2001, 24:167-202.
38. Moy S.S., Nadler J.J., Perez A., Barbaro R.P., Johns J.M., Magnuson T.R., Piven J., Crawley J.N. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav. 2004, 3:287-302.
39. Palin K., Bluthe R.M., McCusker R.H., Moos F., Dantzer R., Kelley K.W. TNFalpha-induced sickness behavior in mice with functional 55kD TNF receptors is blocked by central IGF-I. J. Neuroimmunol. 2007, 187:55-60.
40. Pan W., Kastin A.J. TNFalpha transport across the blood-brain barrier is abolished in receptor knockout mice. Exp. Neurol. 2002, 174:193-200.
41. Peng S., Wuu J., Mufson E.J., Fahnestock M. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. J. Neurochem. 2005, 93:1412-1421.
42. Peschon J.J., Torrance D.S., Stocking K.L., Glaccum M.B., Otten C., Willis C.R., Charrier K., Morrissey P.J., Ware C.B., Mohler K.M. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J. Immunol. 1998, 160:943-952.
43. Petit-Demouliere B., Chenu F., Bourin M. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology (Berl.) 2005, 177:245-255.
44. Sei H., Saitoh D., Yamamoto K., Morita K., Morita Y. Differential effect of short-term REM sleep deprivation on NGF and BDNF protein levels in the rat brain. Brain Res. 2000, 877:387-390.
45. Shepherd J.K., Grewal S.S., Fletcher A., Bill D.J., Dourish C.T. Behavioural and pharmacological characterisation of the elevated zero-maze as an animal model of anxiety. Psychopharmacology (Berl.) 1994, 116:56-64.
46. Shu H.B., Takeuchi M., Goeddel D.V. The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:13973-13978.
47. Simen B.B., Duman C.H., Simen A.A., Duman R.S. TNFalpha signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biol. Psychiatry 2006, 59:775-785.
48. Sofroniew M.V., Howe C.L., Mobley W.C. Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 2001, 24:1217-1281.
49. Song H., Stevens C.F., Gage F.H. Astroglia induce neurogenesis from adult neural stem cells. Nature 2002, 417:39-44.
50. Stellwagen D., Beattie E.C., Seo J.Y., Malenka R.C. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J. Neurosci. 2005, 25:3219-3228.
51. Sweatt J.D. Hippocampal function in cognition. Psychopharmacology (Berl.) 2004, 174:99-110.
52. Takei Y., Laskey R. Interpreting crosstalk between TNF-alpha and NGF: potential implications for disease. Trends Mol. Med. 2008, 14:381-388.
53. Tobinick E. Perispinal etanercept: a new therapeutic paradigm in neurology. Expert Rev. Neurother. 2010, 10:985-1002.
54. Tobinick E., Gross H., Weinberger A., Cohen H. TNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot study. MedGenMed 2006, 8:25.
55. Turnbull A.V., Pitossi F.J., Lebrun J.J., Lee S., Meltzer J.C., Nance D.M., del Rey A., Besedovsky H.O., Rivier C. Inhibition of tumor necrosis factor-alpha action within the CNS markedly reduces the plasma adrenocorticotropin response to peripheral local inflammation in rats. J. Neurosci. 1997, 17:3262-3273.
56. Yamada K., Iida R., Miyamoto Y., Saito K., Sekikawa K., Seishima M., Nabeshima T. Neurobehavioral alterations in mice with a targeted deletion of the tumor necrosis factor-alpha gene: implications for emotional behavior. J. Neuroimmunol. 2000, 111:131-138.
57. You Z., Luo C., Zhang W., Chen Y., He J., Zhao Q., Zuo R., Wu Y. Pro- and anti-inflammatory cytokines expression in rat's brain and spleen exposed to chronic mild stress: involvement in depression. Behav. Brain Res. 2011, 225:135-141.
58. Zhao C., Deng W., Gage F.H. Mechanisms and functional implications of adult neurogenesis. Cell 2008, 132:645-660.